five patients with malignant arterial hypertension and terminal ( 3 ) or advanced ( 2 ) renal failure were treated with the alpha-beta blocker labetalol and the angiotensin-converting enzyme inhibitor captopril .
C0020540
malignant arterial hypertension
C0022860
labetalol